№ lp_2_1_13463
File format: docx
Character count: 43158
File size: 3609 KB
PEHO syndrome is a clinically and genetically diverse entity, representing a phenotypic end-point of various severe genetic encephalopathies, highlighting significant heterogeneity in clinical and genetic presentations.
Year:
2021
Region / city:
Cambridge, United Kingdom
Theme:
Genetics, Epilepsy, Neurology
Document Type:
Research Article
Institution:
Addenbrookes Hospital, University of Cambridge, North West Thames Regional Genetics Service, Royal Hospital for Children & University of Glasgow, Nottingham University Hospitals NHS Trust
Author:
Manali Chitre, Michael S Nahorski, Kaitlin Stouffer, Bryony Dunning-Davies, Hamish Houston, Emma L Wakeling, Angela F Brady, Sameer M Zuberi, Mohnish Suri, Alasdair PJ Parker, C. Geoffrey Woods
Target Audience:
Researchers, clinicians, medical professionals
Period of Validity:
N/A
Approval Date:
N/A
Modification Date:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
United Kingdom
Subject:
Epilepsy Care, Healthcare Quality Improvement, Clinical Audits
Document Type:
Clinical Audit Specification
Organ / Institution:
Healthcare Quality Improvement Partnership (HQIP)
Author:
Not specified
Target Audience:
Healthcare providers, clinicians, policymakers, patients, and the public
Period of Effectiveness:
Ongoing
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
[DD/MM/YYYY]
Country:
[NAME OF COUNTRY]
Region:
[NAME OF REGION]
Type of document:
Exercise scenario template
Organization:
Ministry of Health
Author:
National Surveillance Director (simulated)
Target audience:
Exercise management team
Exercise type:
Field/full-scale exercise (FSX)
Medical focus:
Haemorrhagic syndrome / Ebola
Exercise components:
Scenario narrative, inject matrix, timeline
Infrastructure focus:
Hospitals, laboratories, transportation system
Emergency functions:
EOC activation, media management, resource coordination
Past incidents referenced:
Crimean-Congo haemorrhagic fever case four months prior
Year:
2023
Region / City:
Canberra, Australian Capital Territory (ACT)
Theme:
Acute Coronary Syndrome, STEMI, Medical Procedure
Document Type:
Standard Operating Procedure
Organization / Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Health care professionals working in acute coronary syndrome management
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Last Update:
Not specified
Year:
2023
Region / City:
United States
Topic:
Infectious diseases, prevention, and treatment
Document type:
Health advisory
Organization / Institution:
Centers for Disease Control and Prevention (CDC)
Author:
Centers for Disease Control and Prevention (CDC)
Target audience:
General public
Date of approval:
Not specified
Date of changes:
Not specified
Year:
2025
Date:
13 May 2025
Event Type:
Webinar
Organizer:
Institute and Faculty of Actuaries
Speaker:
James Nicholl (APR LLP)
Supporting Speakers:
Amar, Imelda, Joynal, Sammy, Ahmed, Asees
Topic:
Imposter Syndrome, Confidence in Mathematics Careers
Target Audience:
Students, Early-career actuaries
Location:
Online / United Kingdom
Related Fields:
Actuarial Science, Mathematics, Data Science, AI, Climate Change, Sustainability
Year:
2026
Region / City:
MO HealthNet
Topic:
Dravet Syndrome, Anticonvulsants
Document Type:
Proposal
Organization:
MO HealthNet
Author:
MO HealthNet and Conduent
Target Audience:
Healthcare providers, MO HealthNet participants
Effective Period:
Ongoing
Approval Date:
January 20, 2026
Amendment Date:
N/A
Year:
2024
Region / City:
East London
Topic:
Medical Condition Management
Document Type:
Policy
Organization / Institution:
East London NHS Foundation Trust
Author:
Professional Development Lead Dietitian, ELFT; Clinical Lead Pharmacist, CHS Newham
Target Audience:
Healthcare Professionals
Period of Validity:
January 2025 - December 2027
Approval Date:
13th December 2024
Ratification Date:
22nd January 2025
Last Review Date:
December 2024
Next Review Date:
December 2027
Year:
2013
Region / city:
Global
Subject:
Antiphospholipid Syndrome (APS) Diagnosis and Treatment Guidelines
Document Type:
Medical Guideline
Organization / Institution:
AmSECT
Author:
Not specified
Target Audience:
Healthcare professionals, medical practitioners
Effective Date:
2013
Date of Approval:
Not specified
Date of Revision:
Not specified
Related Documents:
Angiomax/Bivalirudin Clinical Protocol
References:
Gomez, J.A., Cervera, R. Diagnosis and Classification of the Antiphospholipid Syndrome. Journal of Autoimmunity. 2013; 48-49:20-25. Cho H, Jeon Y, Hong DM, Kim HJ, Min JJ. Anesthetic Management of Antiphospholipid Syndrome Patients who underwent Cardiac Surgery. Korean Journal of Anesthesiology. 2014; 66(2):164-168.
Disclaimer:
In emergency situations, immediate life support measures of whatever appropriate nature come first with attention turning to measures described in this protocol/process as soon as possible and practical.
Context:
Medical guideline on the management of Antiphospholipid Syndrome (APS) with a focus on cardiovascular surgical procedures, addressing diagnosis, treatment, and perfusion pump considerations.
Year:
2019
Region / city:
New Zealand
Topic:
Antenatal screening, Down syndrome, genetic disorders, trisomy 21, trisomy 18, trisomy 13
Document type:
Monitoring report
Organization / institution:
National Screening Unit
Author:
National Screening Unit
Target audience:
Healthcare professionals, policymakers, researchers
Period of validity:
N/A
Approval date:
May 2023
Date of amendments:
N/A
Committee:
Infectious Disease
Document type:
Position statement
Proposed title:
Standardized Case Definition for Alpha-Gal Syndrome
Condition:
Alpha-Gal Syndrome
Alternative names:
Red meat allergy; Alpha-gal allergy
Purpose:
Disease surveillance
Geographic scope:
United States
Associated vector:
Ticks
Primary vector species:
Lone star tick (Amblyomma americanum)
Surveillance focus:
Case definition and reporting criteria
Intended users:
Public health authorities
Timeframe referenced:
2010–2018
Organ / institution:
Council of State and Territorial Epidemiologists
Year:
2016
Region / City:
UK
Topic:
Dermatology, Acute cutaneous drug reactions
Document Type:
Medical Guidelines
Organization:
British Association of Dermatologists (BAD)
Author:
Creamer, D., Walsh, S. A., Dziewulski, P., Smith, C. H.
Target Audience:
Healthcare professionals
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Contextual description:
Medical guidelines for the identification and management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, including causes, treatment, and mortality prediction.
Note:
Year
Subject:
Veterinary diagnostics
Document type:
Research/Diagnostic guideline
Organization:
Cornell Animal Health Diagnostic Center
Target audience:
Veterinarians
Year:
2023
Region / city:
Not specified
Topic:
Health, Mortality Risk, Body Roundness Index (BRI)
Document type:
Research Supplement
Institution:
Not specified
Author:
Not specified
Target audience:
Researchers, Public health professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
Not specified
Date:
21 May 2025
Location:
Santa Cruz, Laguna, Philippines
Organization:
International Rice Research Institute (IRRI)
Lead Scientist:
Dr. Van Schepler-Luu
Contributing Scientist:
Dr. Gilda Jonson
Collaborating Institutions:
Department of Agriculture – Regional Crop Protection Center (RCPC); Sta. Cruz Municipal Agriculture Office
Subject:
First documented case of rice yellowing syndrome in the Philippines
Viruses Identified:
Rice Grassy Stunt Virus (RGSV); Rice Ragged Stunt Virus (RRSV)
Rice Variety Affected:
LAV666 (Jackpot 102)
Diagnostic Methods:
RT-PCR; ELISA; PCR
Vector:
Brown planthopper (Nilaparvata lugens)
Reported Impact:
Severe yield reduction (16 cavans vs. expected 200 cavans)
Historical Reference:
Yellowing syndrome first reported in Mekong Delta, Vietnam, 1989
Citation:
Jonson, G. and Schepler-Luu, V. (2025). IRRI identifies the first case of rice yellowing syndrome in the Philippines. Zenodo. https://doi.org/10.5281/zenodo.15479438
License:
CC-BY
Year:
2025
Region / City:
United States
Topic:
Rett Syndrome, Neurology, Therapy
Document Type:
Educational Program
Organization:
Global Education Group, MedliveCME, LLC, National Organization for Rare Disorders (NORD), International Rett Syndrome Foundation (IRSF)
Author:
Grace Correa, Timothy Feyma, Jennifer Martelle Tu
Target Audience:
Pediatric neurologists, neurologists, gastroenterologists, advanced practice practitioners, speech therapists, physical therapists, occupational therapists, pediatricians
Period of Action:
August 20, 2025 - August 20, 2026
Approval Date:
August 20, 2025
Modification Date:
Not provided
Year:
2021
Region / City:
Southeast Asia, Australia, India
Topic:
White Spot Syndrome Virus Infection
Document Type:
Technical Report
Author:
International Committee on Taxonomy of Viruses (ICTV)
Target Audience:
Researchers, Marine Biologists
Period of Action:
Ongoing
Approval Date:
2021
Date of Changes:
Not specified